SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Art Pappas will speak at the Drug Repositioning Summit on October 6 in Boston, MA
News | 10. 06. 2008
